These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18242088)

  • 21. Recent advances in drug discovery of benzothiadiazine and related analogs as HCV NS5B polymerase inhibitors.
    Das D; Hong J; Chen SH; Wang G; Beigelman L; Seiwert SD; Buckman BO
    Bioorg Med Chem; 2011 Aug; 19(16):4690-703. PubMed ID: 21798747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitors of HCV NS5B polymerase: synthesis and structure-activity relationships of unsymmetrical 1-hydroxy-4,4-dialkyl-3-oxo-3,4-dihydronaphthalene benzothiadiazine derivatives.
    Krueger AC; Madigan DL; Green BE; Hutchinson DK; Jiang WW; Kati WM; Liu Y; Maring CJ; Masse SV; McDaniel KF; Middleton TR; Mo H; Molla A; Montgomery DA; Ng TI; Kempf DJ
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2289-92. PubMed ID: 17300933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitors of HCV NS5B polymerase: synthesis and structure-activity relationships of N-1-heteroalkyl-4-hydroxyquinolon-3-yl-benzothiadiazines.
    Pratt JK; Donner P; McDaniel KF; Maring CJ; Kati WM; Mo H; Middleton T; Liu Y; Ng T; Xie Q; Zhang R; Montgomery D; Molla A; Kempf DJ; Kohlbrenner W
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1577-82. PubMed ID: 15745800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitors of hepatitis C virus polymerase: synthesis and characterization of novel 2-oxy-6-fluoro-N-((S)-1-hydroxy-3-phenylpropan-2-yl)-benzamides.
    Cheng CC; Shipps GW; Yang Z; Kawahata N; Lesburg CA; Duca JS; Bandouveres J; Bracken JD; Jiang CK; Agrawal S; Ferrari E; Huang HC
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2119-24. PubMed ID: 20219368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A cell-based assay for RNA synthesis by the HCV polymerase reveals new insights on mechanism of polymerase inhibitors and modulation by NS5A.
    Ranjith-Kumar CT; Wen Y; Baxter N; Bhardwaj K; Cheng Kao C
    PLoS One; 2011; 6(7):e22575. PubMed ID: 21799903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-based design of a benzodiazepine scaffold yields a potent allosteric inhibitor of hepatitis C NS5B RNA polymerase.
    Vandyck K; Cummings MD; Nyanguile O; Boutton CW; Vendeville S; McGowan D; Devogelaere B; Amssoms K; Last S; Rombauts K; Tahri A; Lory P; Hu L; Beauchamp DA; Simmen K; Raboisson P
    J Med Chem; 2009 Jul; 52(14):4099-102. PubMed ID: 19507864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Further SAR studies on novel small molecule inhibitors of the hepatitis C (HCV) NS5B polymerase.
    Reddy TJ; Chan L; Turcotte N; Proulx M; Pereira OZ; Das SK; Siddiqui A; Wang W; Poisson C; Yannopoulos CG; Bilimoria D; L'Heureux L; Alaoui HM; Nguyen-Ba N
    Bioorg Med Chem Lett; 2003 Oct; 13(19):3341-4. PubMed ID: 12951122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Substituted benzothiadizine inhibitors of Hepatitis C virus polymerase.
    Shaw AN; Tedesco R; Bambal R; Chai D; Concha NO; Darcy MG; Dhanak D; Duffy KJ; Fitch DM; Gates A; Johnston VK; Keenan RM; Lin-Goerke J; Liu N; Sarisky RT; Wiggall KJ; Zimmerman MN
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4350-3. PubMed ID: 19515564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 3-Hydroxyisoquinolines as inhibitors of HCV NS5b RNA-dependent RNA polymerase.
    Hendricks RT; Spencer SR; Blake JF; Fell JB; Fischer JP; Stengel PJ; Leveque VJ; Lepogam S; Rajyaguru S; Najera I; Josey JA; Swallow S
    Bioorg Med Chem Lett; 2009 Jan; 19(2):410-4. PubMed ID: 19070486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific inhibitors of HCV polymerase identified using an NS5B with lower affinity for template/primer substrate.
    McKercher G; Beaulieu PL; Lamarre D; LaPlante S; Lefebvre S; Pellerin C; Thauvette L; Kukolj G
    Nucleic Acids Res; 2004; 32(2):422-31. PubMed ID: 14739234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and synthesis of 3,4-dihydro-1H-[1]-benzothieno[2,3-c]pyran and 3,4-dihydro-1H-pyrano[3,4-b]benzofuran derivatives as non-nucleoside inhibitors of HCV NS5B RNA dependent RNA polymerase.
    Gopalsamy A; Aplasca A; Ciszewski G; Park K; Ellingboe JW; Orlowski M; Feld B; Howe AY
    Bioorg Med Chem Lett; 2006 Jan; 16(2):457-60. PubMed ID: 16274990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1,5-benzodiazepines, a novel class of hepatitis C virus polymerase nonnucleoside inhibitors.
    Nyanguile O; Pauwels F; Van den Broeck W; Boutton CW; Quirynen L; Ivens T; van der Helm L; Vandercruyssen G; Mostmans W; Delouvroy F; Dehertogh P; Cummings MD; Bonfanti JF; Simmen KA; Raboisson P
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4420-31. PubMed ID: 18852280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies of benzothiadiazine derivatives as hepatitis C virus NS5B polymerase inhibitors using 3D-QSAR, molecular docking and molecular dynamics.
    Wang X; Yang W; Xu X; Zhang H; Li Y; Wang Y
    Curr Med Chem; 2010; 17(25):2788-803. PubMed ID: 20586716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery and preliminary SAR of benzimidazole derivatives.
    Beaulieu PL; Bös M; Bousquet Y; Fazal G; Gauthier J; Gillard J; Goulet S; LaPlante S; Poupart MA; Lefebvre S; McKercher G; Pellerin C; Austel V; Kukolj G
    Bioorg Med Chem Lett; 2004 Jan; 14(1):119-24. PubMed ID: 14684311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological activity of heteroaryl 3-(1,1-dioxo-2H-(1,2,4)-benzothiadizin-3-yl)-4-hydroxy-2(1H)-quinolinone derivatives as hepatitis C virus NS5B polymerase inhibitors.
    Tedesco R; Chai D; Darcy MG; Dhanak D; Fitch DM; Gates A; Johnston VK; Keenan RM; Lin-Goerke J; Sarisky RT; Shaw AN; Valko KL; Wiggall KJ; Zimmerman MN; Duffy KJ
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4354-8. PubMed ID: 19505821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 3D-QSAR and docking studies on a series of benzothiadiazine derivatives as genotype 1 HCV polymerase inhibitors.
    Patil VM; Gupta SP; Samanta S; Masand N
    Med Chem; 2012 Nov; 8(6):1099-107. PubMed ID: 22779799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-nucleoside inhibitors binding to hepatitis C virus NS5B polymerase reveal a novel mechanism of inhibition.
    Biswal BK; Wang M; Cherney MM; Chan L; Yannopoulos CG; Bilimoria D; Bedard J; James MN
    J Mol Biol; 2006 Aug; 361(1):33-45. PubMed ID: 16828488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crystal structures of the RNA-dependent RNA polymerase genotype 2a of hepatitis C virus reveal two conformations and suggest mechanisms of inhibition by non-nucleoside inhibitors.
    Biswal BK; Cherney MM; Wang M; Chan L; Yannopoulos CG; Bilimoria D; Nicolas O; Bedard J; James MN
    J Biol Chem; 2005 May; 280(18):18202-10. PubMed ID: 15746101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of [(naphthalene-1-carbonyl)-amino]-acetic acid derivatives as nonnucleoside inhibitors of HCV NS5B RNA dependent RNA polymerase.
    Gopalsamy A; Lim K; Ellingboe JW; Krishnamurthy G; Orlowski M; Feld B; van Zeijl M; Howe AY
    Bioorg Med Chem Lett; 2004 Aug; 14(16):4221-4. PubMed ID: 15261274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aryl uracil inhibitors of hepatitis C virus NS5B polymerase: synthesis and characterization of analogs with a fused 5,6-bicyclic ring motif.
    Krueger AC; Randolph JT; DeGoey DA; Donner PL; Flentge CA; Hutchinson DK; Liu D; Motter CE; Rockway TW; Wagner R; Beno DW; Koev G; Lim HB; Beyer JM; Mondal R; Liu Y; Kati WM; Longenecker KL; Molla A; Stewart KD; Maring CJ
    Bioorg Med Chem Lett; 2013 Jun; 23(12):3487-90. PubMed ID: 23664214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.